Shares of Generex Biotechnology Corporation (OTC: GNBT), a development stage company engaged in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases, are soaring in trading today. At last check, GNBT shares were trading 24% higher at $0.0372 on above average volume of 15.56 million. The stock hit [...]
Recent Comments